IMR Press / FBL / Volume 21 / Issue 1 / DOI: 10.2741/4373

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Review

The progress of molecular diagnostics of osteosarcoma

Show Less
1 Jinling Hosp, Dept Orthopedics, Nanjing Univ, Sch Med, Nanjing 210002, Peoples R China
Academic Editor:Wei Qin
Front. Biosci. (Landmark Ed) 2016, 21(1), 20–30; https://doi.org/10.2741/4373
Published: 1 January 2016
(This article belongs to the Special Issue Pathogenesis and diagnostic modalities in cancer)
Abstract

Despite significant advances in the diagnosis and treatment of osteosarcoma in recent years, overall survival has remained low for over 2 decades. The standard diagnosis of osteosarcoma requires a combination of clinical presentation, radiologic studies, and pathologic tissue evaluation. A typical “Codman’s triangle” in radiologic evaluation is vital in making correct diagnosis for middle or late stage of osteosarcoma. However, there is an actual demand for novel molecular markers with high sensitivity and stability for the diagnosis of early events of osteosarcoma and also the probability of recurrence and metastasis. Except that, some highly relevant gene mutations with these events could also provide valuable information regarding osteosarcoma protection. In this review, we will focus on the molecular markers which have been discovered in recent years with potential application of early stage and recurrence diagnosis and protection.

Keywords
Retinoblastoma
Mesenchymal
MicroRNA
Review
Share
Back to top